Skip to main content
SpringerLink
Log in

The meaning of microalbuminuria in type 1 diabetes: The need for a new paradigm

  • Clinical Trials Report
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984, 311:89–93.

    Article  PubMed  CAS  Google Scholar 

  2. Parving H-H, Oxenboll B, Svendsen PA: Early detection of patients at risk of developing diabetic nephropathy. A prospective study of urinary albumin excretion. Acta Endocrinol 1982, 100:550–555.

    PubMed  CAS  Google Scholar 

  3. Mathiesen ER, Oxenboll B, Johansen K, et al.: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984, 26:406–410.

    Article  PubMed  CAS  Google Scholar 

  4. Bakris GL: Microalbuminuria: prognostic implications. Curr Opin Nephrol Hypertens 1996, 5:219–223.

    Article  PubMed  CAS  Google Scholar 

  5. Jager A, Kostense PJ, Ruhe HG, et al.: Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999, 19:617–624.

    PubMed  CAS  Google Scholar 

  6. Tuttle KR, Puhlman ME, Cooney SK, Short R: Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. Am J Kidney Dis 1999, 34:918–925.

    PubMed  CAS  Google Scholar 

  7. Valmadrid CT, Klein R, Moss SE, Klein BE: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with olderonset diabetes mellitus. Arch Intern Med 2000, 160:1093–1100.

    Article  PubMed  CAS  Google Scholar 

  8. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B: Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Colch) 1995, 88:629–633.

    CAS  Google Scholar 

  9. Agewall S, Wikstrand J, Ljungman S, Fagerberg B: Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997, 80:164–169.

    Article  PubMed  CAS  Google Scholar 

  10. Jarrett RJ, Viberti GC, Argyropoulos A, et al.: Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1984, 1:17–19.

    Article  PubMed  CAS  Google Scholar 

  11. Chavers BM, Bilous RW, Ellis EN, et al.: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 1989, 320:966–970.

    Article  PubMed  CAS  Google Scholar 

  12. Fioretto P, Steffes MW, Mauer M: Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 1994, 43:1358–1364.

    Article  PubMed  CAS  Google Scholar 

  13. Viberti GF: Prognostic significance of albuminuria for the development of nephropathy. J Hypertens Suppl 1995, 13:S87-S89.

    Article  PubMed  CAS  Google Scholar 

  14. Mauer SM, Steffes MW, Ellis EN, et al.: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984, 74:1143–1155.

    PubMed  CAS  Google Scholar 

  15. Fioretto P, Steffes MW, Sutherland DE, et al.: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69–75.

    Article  PubMed  CAS  Google Scholar 

  16. Del Prete D, Anglani F, Ceol M, et al.: Molecular biology of diabetic glomerulosclerosis. Nephrol Dial Transplant 1998, 13(suppl 8):20–25.

    Article  PubMed  Google Scholar 

  17. Duncan MR, Frazier KS, Abramson S, et al.: Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999, 13:1774–1786.

    PubMed  CAS  Google Scholar 

  18. Flyvbjerg A: Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000, 43:1205–1223.

    Article  PubMed  CAS  Google Scholar 

  19. Gambaro G, Baggio B: Growth factors and the kidney in diabetes mellitus. Crit Rev Clin Lab Sci 1998, 35:117–151.

    Article  PubMed  CAS  Google Scholar 

  20. Ito Y, Aten J, Bende RJ, et al.: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998, 53:853–861.

    Article  PubMed  CAS  Google Scholar 

  21. Murphy M, Godson C, Cannon S, et al.: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999, 274:5830–5834.

    Article  PubMed  CAS  Google Scholar 

  22. Rossert J, Terraz-Durasnel C, Brideau G: Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy. Diabetes Metab 2000, 26(suppl 4):16–24.

    PubMed  CAS  Google Scholar 

  23. Riser BL, Ladson-Wofford S, Sharba A, et al.: TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. Kidney Int 1999, 56:428–439.

    Article  PubMed  CAS  Google Scholar 

  24. Riser BL, Denichilo M, Cortes P, et al.: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000, 11:25–38.

    Article  PubMed  CAS  Google Scholar 

  25. Mclennan SV, Death AK, Fisher EJ, et al.: The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol 1999, 45:123–135.

    PubMed  CAS  Google Scholar 

  26. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1991, 139:889–899.

    PubMed  CAS  Google Scholar 

  27. Wu K, Setty S, Mauer SM, et al.: Altered kidney matrix gene expression in early stages of experimental diabetes. Acta Anat (Basel) 1997, 158:155–165.

    CAS  Google Scholar 

  28. Brown DM, Charonis AS, Furcht LT, et al.: An overview of role of matrix components. Diabetes Care 1991, 14:157–159.

    Article  PubMed  CAS  Google Scholar 

  29. Esposito C, Striker LJ, Patel A, et al.: Molecular analysis of glomerular diseases in renal biopsies: initial results of a collaborative international study. The International Study Group for Molecular Study of Kidney Biopsies. Proc Assoc Am Physicians 1996, 108:209–217.

    PubMed  CAS  Google Scholar 

  30. Adler SG, Feld S, Striker GE, et al.: Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int 2000, 57:2084–2092.

    Article  PubMed  CAS  Google Scholar 

  31. Ledbetter S, Copeland EJ, Noonan D, et al.: Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 1990, 39:196–203.

    Article  PubMed  CAS  Google Scholar 

  32. Yang CW, Hsueh S, Wu MS, et al.: Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosisapplication in renal biopsies. Nephron 1997, 77:290–297.

    Article  PubMed  CAS  Google Scholar 

  33. Mauer SM, Chavers BM, Steffes MW: Should there be an expanded role for kidney biopsy in the management of patients with type I diabetes? Am J Kidney Dis 1990, 16:96–100.

    PubMed  CAS  Google Scholar 

  34. Glassock RJ, Hirschman GH, Striker GE: Workshop on the use of renal biopsy in research on diabetic nephropathy: a summary report. Am J Kidney Dis 1991, 18:589–592.

    PubMed  CAS  Google Scholar 

  35. Adler SG, Kang SW, Feld S, et al.: Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. J Am Soc Nephrol 2001, in press.

  36. Adler SG, Kang SW, Feld S, et al.: In IDDM, elevated glomerular CTGF and collagen alpha2(IV) mRNA levels reflect albuminuria and may predict progression from normoalbuminuria. J Am Soc Nephrol 2000, 11:112A.

    Google Scholar 

  37. Kestila M, Lenkkeri U, Mannikko MEA: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1:575–582.

    Article  PubMed  CAS  Google Scholar 

  38. Holtzman LB, John PL, Kovari A, et al.: Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 1999, 56:1481–1491.

    Article  Google Scholar 

  39. Adler SG, Shahed A, Kang SW, et al.: 12-lipoxygenase, p38 MAPK, and collagen alpha5(IV) in glomeruli in streptozotocin diabetic nephropathy and in glucose stimulated podocytes. J Am Soc Nephrol 2001, in press.

  40. Kang SW, Adler SG, Lapage J, Natarajan R: Glomerular p38 mitogen-activated protein kinase (MAPK) and MAPK kinase 3/6 mRNA expression and activity are increased in early diabetic nephropathy. Kidney Int 2001, 60:543–552.

    Article  PubMed  CAS  Google Scholar 

  41. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria. Diabetologia 1999, 42:1341–1344.

    Article  PubMed  CAS  Google Scholar 

  42. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al.: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342–348.

    PubMed  CAS  Google Scholar 

  43. Nakamura T, Ushiyama C, Shimada N, et al.: Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy. Diabetes Care 2000, 23:1168–1171.

    Article  PubMed  CAS  Google Scholar 

  44. Nakamura T, Ushiyama C, Suzuki S, et al.: Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 2000, 15:1379–1383.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, 90502, Torrance, CA, USA

    Sharon G. Adler MD

Authors
  1. Sharon G. Adler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia C. Nast MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adler, S.G., Nast, C.C. The meaning of microalbuminuria in type 1 diabetes: The need for a new paradigm. Curr Diab Rep 1, 241–244 (2001). https://doi.org/10.1007/s11892-001-0041-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-001-0041-7

Keywords

Search

Navigation